Industry & Company Headlines

• US FDA Panel to Review Laser Eye Surgery
  Dr. Daniel Schultz, director of FDA's Center for Devices and Radiological Health, said a number of concerns have been raised concerning patient satisfaction with the vision correction procedure, known as laser-assisted in situ keratomileusis, or LASIK ... read more
• Biotech Firms Turn to Reverse Mergers in Slow IPO Market
  With the initial public offering market slowing, many private biotech companies are going the reverse merger route, seeking to combine their operations with either public companies that have fallen on hard times or public shells to gain access to capital markets ... read more
• Want Generic Biotech? You Might Wait 14 More Years
  New legislation introduced by Eshoo (D-CA) and Barton (R-TX) in the House of Representatives provides a regulatory pathway for approving generic biotech drugs. But not everyone is cheering ... continue
  • Read BIO's statement
  • Read GPhA's Statement
• CSU Channel Island's University Glen Corporation Released RFP to Develop a Research Park on 27 Acres of Land in Camarillo ... To learn more about this project, RSVP for the SoCalBio Networking Forum on March 27
• Amgen to Use Lab21's Diagnostic Test to See Which Patients Are Suitable for its Cancer Drug Vectibix
  Cambridge, England-based Lab21 has been selected by Amgen to screen patients who are going to be prescribed Vectibix for the K-ras mutation to see whether or not they are likely to benefit from the drug. Financial terms weren't disclosed ... read more
• Other Headlines:
• Abraxis Bioscience Announces Filing of Marketing Application in Japan for ABRAXANE
• Calando Files IND for siRNA Therapeutic in Oncology
• Nevada Department of Corrections Extends Contract with CompuMed, Inc. to Provide Remote ECG Screening
• I-Flow Leads Infection Prevention Trend by Using Silver with Antimicrobial Properties in Medical Devices
• STAAR Surgical's Collamer(R) IOL Designated as a New Technology Intraocular Lens by CMMS
• Valeant Pharmaceuticals Reports Encouraging Phase IIb Results at Treatment Week 12 for Taribavirin
• Watson Files FDA Application for Generic LYBREL
• Wyeth Sues Watson in Patent Dispute

Jobs Available

HairDx (Irvine)
http://www.hairdx.com

• Sr. Genetics Analyst with experience working with large genotype-phenotype databases
• Sr. Software Developer with experience working with ASP.Net and SQL Server applications
• Marketing Manager with experience in developing Web-based marketing campaigns

Cougar Biotechnology (West Los Angeles)
http://www.cougarbiotechnology.com

• Director, Clinical Research and Development
• Associate Director/Director/Senior Director, Drug Safety and Pharmacovigilance
• Manager, Quality Assurance
• Associate Director / Director, Regulatory Affairs Operations
• Clinical Trial Specialist/Sr. Clinical Trial Specialist
• Associate Clinical Trial Manager/Clinical Trial Manager/Sr. Clinical Trial Manager
• Sr. Manager/Associate Director, Clinical Data Management
• Sr. Manager/Associate Director, Biostatistics
• Senior Director, Regulatory Affairs

Register Now

SoCalBio Networking Forum
March 27, 2008
4 to 7 pm
UCLA Faculty Club (Westwood, CA)

RSVP: https://www.123signup.com/register?id=ttrmq

Personalized Medicine
Are We There Yet?

Personalized medicine is the practice of tailoring treatment to patients and their diseased cells based on genetic/genomic knowledge and health information technology. It is a therapeutic modality fueled by the genetic data and diagnostic tools that emerged following the decoding of the human genome about ten years ago. Personalized medicine represents a paradigm shift in health care requiring a whole new approach to science, but progress in making it a reality has been slow. Although many biotech firms and institutional researchers are rallying around personalized medicine, the timeline to new therapies is still being recalibrated. Join us to learn from local companies about the prospects of personalized medicine and consumer genomics.

Speakers 

• Andy Goren, CEO, HairDx (Irvine)
• Walter Narajowski, President & CEO, Pathway Diagnostics (Malibu)
• Peggy Pence, Ph.D., President & CEO, Symbion Research International (Agoura Hills)
• Robert Terbrueggen, Ph.D., President & CEO, DxTerity Diagnostics (Rancho Dominguez)

Recommended Events

March 29, 2008
3^rd Annual Biomedical Forum

Organized by SABPA (Sino-American Biomedical and Pharmaceutical Professionals Association) at the Hyatt Regency in Huntington Beach .. click here for more information

Real Estate

About SoCalBio

Access Past Weekly Updates

• March 11, 2008
• March 6, 2008
• February 25, 2008
• February 19, 2008

• February 11, 2008
• February 6, 2008
• February 1, 2008
• January 21, 2008